AusCann Group Holdings Ltd (ASX: AC8) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

AusCann Group Holdings Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $17.62 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 440.55 million
Earnings per share -0.002
Dividend per share N/A
Year To Date Return N/A
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • AusCann Group Holdings Ltd (ASX: AC8)
    Latest News

    Bottles and vials of hemp oil in a row next to a spoon filled with hemp seeds representing asx cannabis shares
    Share Market News

    ASX cannabis shares continue progress despite pandemic

    ASX cannabis shares have reported they've been continuing to work through COVID-19 disruptions as they look to scale their businesses.

    Read more »

    ASX Cannabis share price represented by asx investor holding card with cannabis leaf on it
    Share Market News

    ASX cannabis shares adjust to coronavirus environment

    As the Australian medicinal cannabis industry grows, we take a look at how ASX cannabis shares are facing the coronavirus…

    Read more »

    Share Market News

    Althea share price lifts as cannabis market growth predicted

    The Althea share price is on the rise today following the announcement its subsidiary has entered a cannabis beverage production…

    Read more »

    Share Fallers

    Why AusCann, Phoslock, Kogan, & Village Roadshow are dropping lower

    Kogan.com Ltd (ASX:KGN) and Village Roadshow Ltd (ASX:VRL) are two of four ASX shares dropping lower on Tuesday. Here's why...

    Read more »

    Share Market News

    ASX cannabis shares see mixed recovery

    We take a look at the recovery of ASX cannabis shares through the likes of Althea Group Holdings after the…

    Read more »

    Share Market News

    How did ASX cannabis shares perform in the latest quarter?

    ASX cannabis shares have faced a difficult few months. Struck by a capital crunch earlier this year, cannabis shares were…

    Read more »

    a woman
    Share Market News

    ASX cannabis shares stage a comeback after the March bear market

    ASX cannabis shares are staging a comeback after the March share market correction.

    Read more »

    a woman
    Share Market News

    ASX cannabis shares grow business despite coronavirus downturn

    While the market has been distracted by the fallout from the coronavirus pandemic, ASX cannabis shares have been quietly expanding…

    Read more »

    a woman
    Coronavirus News

    Here's how ASX cannabis shares are being impacted by COVID-19

    Althea Group Holdings Ltd (ASX:AGH) and other ASX cannabis shares have fallen heavily this month because of the coronavirus. Will…

    Read more »

    a woman
    Share Market News

    How did ASX cannabis shares perform this reporting season?

    As February reporting season wraps up, let's take a look at how these ASX cannabis shares performed.

    Read more »

    a woman
    Share Fallers

    Why Afterpay, AMA, AusCann, & Harvey Norman are dropping lower

    Afterpay Ltd (ASX:APT) and Harvey Norman Holdings Limited (ASX:HVN) shares are two of four dropping notably lower on Friday...

    Read more »

    a woman
    Share Market News

    Why this ASX cannabis stock is sinking 20% lower today

    The Auscann Group Holdings Ltd (ASX: AC8) share price is on watch this morning after the ASX cannabis stock reported a…

    Read more »

    AC8 ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About AusCann Group Holdings Ltd

    AusCann Group Holdings Ltd produces medicinal cannabis. It delivers high-quality, economical, and clinically validated cannabinoid medicinal products.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Robert Clifford Non-Executive Director Apr 2021
    Mr Clifford has been at the forefront of Australia and New Zealand's food and beverage industry for over 25 years. An industry professional and expert in food and destination development. Mr Clifford has experience in developing new concepts for a wide range of markets. Beginning his career in hospitality with the Hyatt International Hotels and Resorts, Mr Clifford has held various executive management positions in Perth, Canberra and Macau. Mr Clifford was the Perth Convention Exhibition Centre's Chief Executive Officer before moving to Melbourne, where he led Australia's largest catering brand, EPICURE. Mr Clifford established Alto Cibum Consulting in 2015, providing business strategy to a range of private sector businesses and government bodies. Mr Clifford holds several board positions in listed companies, not for profit and start-up companies. Mr Clifford was privileged to open the Dublin office for the Irish Australian Chamber of Commerce during his tenure as president. He is an active member of the Irish Australian community with involvement in trade negotiations.
    Mr Brett Anthony Mitchell Non-Executive Director Jun 2023
    Mr Mitchell is a corporate finance executive with over 25 years of experience in the venture capital and equity capital markets, on transactions in the natural resources, technology and life sciences sectors. He has been involved in the founding, financing and management of both private and publicly listed companies, including the first LSE listed medical cannabis company - MGC Pharmaceuticals Ltd (MXC), Australian Lithium developer Delta Lithium Ltd (DLI) and private medical cannabis company Levin Health Limited. Mr Mitchell is also the founder and director of Chieftain Securities Pty Ltd, a Perth based specialist Corporate Advisory and ECM firm.
    Mr Andrew Chapman Non-Executive ChairmanNon-Executive Director Dec 2023
    --
    Mr Layton Patrick Mills Chief Executive Officer Mar 2021
    -
    Mr Quentin Heath Megson Chief Financial OfficerJoint Company Secretary Feb 2019
    -
    Mrs Rachel Kerr Company Secretary Jan 2024
    -
    Layton Patrick Mills Chief Executive Officer
    -
    Quentin Heath Megson Chief Financial OfficerJoint Company Secretary
    -
    Rachel Kerr Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    The Trust Company (Australia) Limited <Mof A/C> 56,379,750 12.80%
    Citicorp Nominees Pty Limited 14,166,012 3.22%
    Mr Layton Patrick Mills <Djs Family A/C> 11,387,582 2.58%
    Ms Tania Maree Vidovic <Star V Family A/C> 6,493,082 1.47%
    Mr Poh Seng Tan 5,800,000 1.32%
    Mercedes Mortgage Management Pty Ltd <Mercedes Super Fund A/C> 5,205,000 1.18%
    Mr George Chien Hsun Lu + Mrs Jenny Chin Pao Lu 4,679,999 1.06%
    Pepaanne Pty Ltd <The Chapman Family A/C> 4,600,000 1.04%
    Mr Warren Sidney Langman 4,235,928 0.96%
    Miss Xiaodan Fu 3,856,591 0.88%
    Bnp Paribas Noms Pty Ltd <Drp> 3,631,800 0.82%
    Bnp Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 3,169,183 0.72%
    Mr Paul Robert Papa 3,005,866 0.68%
    Bnp Paribas Nominees Pty Ltd Acf Clearstream 2,634,258 0.60%
    Mr George Chien-Hsun Lu 2,569,999 0.58%
    Lu'S International Limited 2,339,999 0.53%
    Mr Zhijian Chen 2,210,950 0.50%
    Danny Stephens Investments Pty Ltd <Danny Stephens Family A/C> 2,150,200 0.49%
    Noldex Pty Ltd 2,094,918 0.48%
    Joyress Pty Ltd 1,950,000 0.44%
    Mr Dale Cameron Forsyth 1,950,000 0.44%

    Profile

    since

    Note